liarozole - Moligand™, ≥98% , Inhibitor of CYP26A1, CAS No.115575-11-6, Inhibitor of CYP26A1
재고 있음
SKU
L611529
Liarozole is an imidazole derivative and a retinoic acid (RA) metabolism blocker (RAMBA) with antitumor activity. It inhibits retinoic acid-dependent cytochrome P450 (CYP26) 4-hydroxylation (IC50 = 7 μM), leading to increased tissue retinoic acid levels.
추가 정보
| CAS | 115575-11-6 |
|---|---|
| 동의어 | UNII-K0Q29TGV9Y | UGFHIPBXIWJXNA-UHFFFAOYSA-N | 5-[(3-chlorophenyl)(1H-imidazol-1-yl)methyl]-1H-benzimidazole | CHEBI:135316 | F81706 | R 085246 | R-61405 | 1H-Benzimidazole, 5-((3-chlorophenyl)-1H-imidazol-1-ylmethyl)- | Liarozolum | BDBM50157605 | 1H-Be |
| 사양 및 순도 | Moligand™, ≥98% |
| 보관 조건 | Store at 2-8°C,Protected from light,Argon charged,Desiccated |
| 배송 | Wet ice |
| Product Description | Liarozole is an imidazole derivative and a retinoic acid (RA) metabolism blocker (RAMBA) with antitumor activity. It inhibits retinoic acid-dependent cytochrome P450 (CYP26) 4-hydroxylation (IC50 = 7 μM), leading to increased tissue retinoic acid levels. |
| 감도 | light sensitive |
| PubChem CID | 60652 |
| 분자 공식 | C17H13ClN4 |
리뷰
고객 리뷰
We found other products you might like!
-
LiarozoleStarting at US$129.90
Remind me later